Hemianopic and quadrantanopic safe to drive

Article

Hemianopic and quadrantanopic people have been declared safe to drive because they make more head movements into their blind field to compensate, according to a recent study published in Investigative Ophthalmology and Visual Science.

Hemianopic and quadrantanopic people have been declared safe to drive because they make more head movements into their blind field to compensate, according to a recent study published in Investigative Ophthalmology and Visual Science.

A team led by Joanne M. Wood et al., Queensland University of Technology, Queensland, Australia, studied eye and head movements and lane keeping in 22 participants with homonymous hemianopic defects, 8 participants with quadrantanopic defects and 30 participants with normal vision fields. All participants drove a 6.3 mile route and were objectively assessed on speed, acceleration, braking and cornering.

Findings showed that hemianopic and quadrantanopic people took more care when cornering, accelerating and braking. Lane position stability and eye movement was superior in those who were rated as safe to drive.

The study suggested that the characteristics demonstrated by the participants could be trained in rehabilitation programs to improve safety in the population.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.